Viz.ai
Revolutionizing patient care in healthcare through advanced AI-powered solutions for disease detection and treatment delivery by Viz.ai.

Viz.ai is a healthcare company that utilizes artificial intelligence (AI) to revolutionize patient care, providing advanced AI-powered solutions for disease detection and treatment delivery. Their offerings include suites for neuro, vascular, cardio, radiology, trauma, and life sciences, which analyze CT scans, EKGs, echocardiograms, and more in real-time to expedite diagnosis and treatment, with clinically validated results saving time and reducing costs.
About Viz.ai
Viz.ai is a pioneering company that leverages artificial intelligence (AI) to revolutionize patient care in the healthcare industry. The mission at Viz.ai is to close the gaps between patients, clinicians, and life-saving treatments by providing advanced AI-powered solutions for disease detection and treatment delivery.
Dr. Snehal Gandhi, Dr. Don Frei, and Dr. Phillip Batista from Cooper University Health Care and Radiology Imaging Associates/RIA Neurovascular and Swedish Medical Center, Denver are among the healthcare professionals who benefit from Viz.ai's offerings. They use Viz.ai to quickly identify and refer individuals at risk for Large Vessel Occlusion (LVO), Intracerebral Hemorrhage (ICH), Cerebral Aneurysm, Subdural Hemorrhage, Cryptogenic Stroke, Pulmonary Embolism, Aortic Disease, Hypertrophic Cardiomyopathy, and other conditions.
Viz.ai offers multiple suites for various medical applications, including Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, Radiology Suite, Trauma Suite, and Life Sciences Market Development. Their AI-powered care coordination solution analyzes CT scans, EKGs, echocardiograms, and more, providing real-time insights and automated assessments to expedite diagnosis and treatment.
Viz.ai's comprehensive solution is clinically validated and has significantly improved patient outcomes by saving time and reducing costs. The company's AI-powered care coordination solution is part of the future of patient care, powered by advanced FDA-cleared algorithms.
